From recent high school graduates to those pursuing advanced degrees, this year’s Vertex Foundation Scholars are chasing their dreams.
Vertex is committed to working alongside the CF community on this journey to support those living with CF.
Learn how we support independent research in cystic fibrosis (CF) through our Vertex CF Research Innovation Awards and Vertex Innovation Awards programs.
Guided by our uncompromising commitment to patients, we are committed to going the distance in cystic fibrosis. Learn more about what we're focused on as we continue our journey.
We are relentless in our quest to improve the lives of people living with serious diseases. Thanks to the dedication of teams led by Paul Negulescu, Sabine Hadida and Fred Van Goor, our medicines have profoundly impacted the cystic fibrosis community, earning recognition such as the prestigious Breakthrough Prize.
The Vertex Foundation Scholarship helps eligible people with cystic fibrosis and their families in the U.S. and Canada pursue higher education degrees. Recipients will be awarded $5,000 USD/CAD toward the 2024-2025 academic year.
Listen to Jason McCartney, Senior Director, Medicinal Chemistry, discuss an overview of the drug discovery process at Vertex Pharmaceuticals.
Watch as our Senior Vice President and San Diego Site Head, Sabine Hadida, breaks down our drug discovery process and the importance of grit, teamwork and determination.
The Vertex Foundation aims to help support the entire family — including educational funding for people living with cystic fibrosis, their loved ones and caregivers.
Listen to James Sinclair, Senior Director of Engineering & Applied Physics, talk about how our engineers partner with our scientists to optimize the drug discovery process.
Learn about how mRNA therapy could potentially benefit people living with serious diseases.
Paul Negulescu, Senior Vice President, Research, talks about the journey his team has taken over the last 20 years.
Listen to Fred Van Goor, Vice President of Cystic Fibrosis Research, talk about our commitment to pursuing new therapeutic advances for all people living with cystic fibrosis and how this commitment drives scientific innovation.
Rebecca Hunt, Vice President of Patient and Community Engagement, highlights Vertex’s uncompromising commitment to patients.
Learn more about cystic fibrosis and how we are committed now more than ever to discovering new therapeutic advances for all people living with the disease.
Mark Higgins, Senior Director of Clinical Development, highlights Vertex’s patient-first approach to clinical trials and discusses his experience discovering potential treatments for people with cystic fibrosis.
Cystic fibrosis is a rare, genetic, progressive disease, in which symptoms and organ damage can manifest very early in life. These may not, however, be outwardly visible in all children and while some children can appear well on the outside, what is happening inside their bodies can tell a different story.
